These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17520987)

  • 1. Urine drug test interpretation: what do physicians know?
    Reisfield GM; Bertholf R; Barkin RL; Webb F; Wilson G
    J Opioid Manag; 2007; 3(2):80-6. PubMed ID: 17520987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family physicians' proficiency in urine drug test interpretation.
    Reisfield GM; Webb FJ; Bertholf RL; Sloan PA; Wilson GR
    J Opioid Manag; 2007; 3(6):333-7. PubMed ID: 18290585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing heroin abuse from codeine administration in the urine of Chinese people by UPLC-MS-MS.
    Bu J; Zhan C; Huang Y; Shen B; Zhuo X
    J Anal Toxicol; 2013 Apr; 37(3):166-74. PubMed ID: 23316032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of codeine positivity in urine of pain management patients.
    Colby JM; Wu AH; Lynch KL
    J Anal Toxicol; 2015 Jun; 39(5):407-10. PubMed ID: 25840440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.
    Starrels JL; Fox AD; Kunins HV; Cunningham CO
    J Gen Intern Med; 2012 Nov; 27(11):1521-7. PubMed ID: 22815062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational use and interpretation of urine drug testing in chronic opioid therapy.
    Reisfield GM; Salazar E; Bertholf RL
    Ann Clin Lab Sci; 2007; 37(4):301-14. PubMed ID: 18000286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
    Bertholf RL; Johannsen LM; Reisfield GM
    J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
    Reisfield GM; Goldberger BA; Bertholf RL
    Bioanalysis; 2009 Aug; 1(5):937-52. PubMed ID: 21083064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using urine drug testing to support healthy boundaries in clinical care.
    Heit HA; Gourlay DL
    J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine.
    Wasan AD; Michna E; Janfaza D; Greenfield S; Teter CJ; Jamison RN
    Pain Med; 2008 Oct; 9(7):918-23. PubMed ID: 18616432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the urine metabolic profile of codeine in pain patients.
    Yee DA; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids.
    Suzuki J; Garayalde S; Dodoo M; Rodriguez C
    Subst Abus; 2018; 39(4):518-521. PubMed ID: 29697313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random urine drug testing among patients receiving opioid therapy for cancer pain.
    Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E
    Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
    Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
    Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary.
    Gourlay D; Heit HA
    Clin Chem; 2009 Oct; 55(10):1769. PubMed ID: 19786588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.